Preclinical studies of an insulin candidate named NNC2215 have shown promise; this smart insulin can alter its own activity in response to glucose concentration in the body Preclinical studies of an insulin candidate named NNC2215 have shown promise; this smart insulin can alter its own activity in response to glucose concentration in the body Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu